Depas and congenital central nervous system anomaly Patient Reports February 12, 2012

Depas Side Effects Report #5339738-0
Depas side effect was reported by a Consumer or non-health professional from JAPAN on May 23, 2007. Male patient, weighting 8.38 lb, was treated with Depas. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: unknown. During the same period patient was treated with SOLANAX, LUDIOMIL. Patient was hospitalized. Patient recovered.

Depas Side Effects Report #5467785-7
Depas side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2007. Male patient, weighting 8.38 lb, was treated with Depas. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: unknown. During the same period patient was treated with ALPRAZOLAM, LUDIOMIL. Patient was hospitalized. Patient recovered.

Depas Side Effects Report #5476574-9
Depas side effect was reported by a Health Professional from JAPAN on Sept 27, 2007. Male patient, weighting 8.40 lb, was treated with Depas. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood urine present, congenital central nervous system anomaly, decreased activity, exercise lack of, feeding disorder, hypercreatininaemia. Depas dosage: unknown. During the same period patient was treated with ALPRAZOLAM, LUDIOMIL. Patient was hospitalized. Patient recovered.